Nova Medical appoints Sudhir Bahl as president & COO
Nova Medical Centers, a multi-specialty day care surgical centre, has appointed Sudhir Bahl as the president and chief operating officer to lead the overall operations of the company. He will be based out of Delhi and will also be the head of Max-NOVO SPV and serve on the board of the SPV. Bahl will be responsible for steering the growth of overall Nova operations in India and additionally be engaged directly in managing the doctor empanelment.

Ecron AcuNova appoints Dr AS Arvind as strategic advisor
Ecron AcuNova has appointed Dr A S Arvind as the strategic advisor. He will guide the company on operational excellence and will mentor the team.

From his immense experience, Arvind will support the clients medically, scientifically and strategically in their clinical development plan. Prior to EA, Dr Arvind was chief operating officer of Clinigene, CRO and a Biocon subsidiary.

Dr Nagendra Swamy promoted as president, Manipal Health Enterprises
Manipal Health Enterprises, one of Asia’s largest healthcare management groups, has announced the promotion of Dr Nagendra Swamy as president, Manipal Health Enterprises.

IISc's Prof Govindasamy Mugesh bags 5 awards in drug research
Indian Institute of Science's (IISc) Prof Govindasamy Mugesh, associate professor, department of Inorganic and Physical Chemistry has bagged five awards this year. The recognitions are for his research on diseases originating from thyroid.

Dr Satya Dash appointed as ABLE COO
The Association of Biotechnology Led Entrepreneurs (ABLE) has appointed Dr Satya Dash as the chief operating officer (COO) . He will now man the operations of the the pan Indian apex biotechnology industry body.

Glenmark Pharma appoints Arvind Vasudeva as COO
Glenmark Pharmaceuticals Limited has appointed Arvind Vasudeva as chief operating officer. Vasudeva will be based at the Corporate headquarters in Mumbai and will report to the CEO & MD, Glenn Saldanha.

Dr Bhushan Patwardhan joins as director, I-AIM,  part of FRLHT
Dr     Bhushan Patwardhan from the University of Pune has taken over as director of the Institute of Ayurveda and Integrative Medicine (I-AIM), the multidisciplinary Research, Education and Outreach arm of the Foundation of Revitalization of Local Health Tradition. He succeeds DK Ved who has superannuated.

Pfizer appoints Mikael Dolsten as president of Worldwide R&D
Pfizer Inc named Mikael Dolsten, president of Pfizer Worldwide Research and Development, as the company completes its integration of these functions following the Wyeth acquisition. Dr Dolsten previously led Wyeth’s Research and Development organization from May 2008, and after the close of the Wyeth acquisition was named president of Pfizer’s BioTherapeutics R&D.

Dr Yati Chugh heads Lotus Labs
Dr Yati Chugh has been appointed as the managing director of Lotus Labs, a leading clinical research organisation. He takes over from Dr Saral Thangam.

Dr Chugh is a pharmacologist by training and has around two decades of experience in conducting Pre-Clinical and Clinical Research D. He has extensive experience in areas of CNS, CVS, Drug metabolism / Pharmacokinetics and Clinical Pharmacology. He has about 20 patents and 40 publications in National and International peer reviewed journals.

Strides Arcolab appoints Manish Gupta to head its Pharma Business
Strides Arcolab has appointed Manish Gupta as chief executive officer - Pharma. The appointment follows the restructuring announced by the company in 2009 and the realignment of its business along three verticals - pharma, specialty and branded generics.

Bishwajeet Roy joins Finar Chemicals as COO
Bishwajeet Roy, a veteran chemical industry professional and ex-executive director of ThermoFisher Scientific has joined Finar Chemicals, an Ahmedabad-based leading manufacturer of Laboratory and Fine Chemicals as the chief operating officer. Roy has an industry experience of 31 years and has held significant portfolios in his career.

Dr C G Murthy elected president of IPA for two-year term
The veteran pharma expert Dr C Gopalakrishna Murthy has been unanimously elected the president of Indian Pharmaceutical Association (IPA) for a two year term from April 1 this year.

Kaushik Desai elected as chairman, Industrial Pharmacy  Division and vice president, IPA
Kaushik Suryakant Desai, chief executive officer & director, Global Pharmatech has been elected as chairman, Industrial Pharmacy Division and vice president of Indian Pharmaceutical Association (IPA) for the period 2010-12.

Prof K K Bhutani appointed new director of NIPER, Punjab
Professor K K Bhutani has been appointed new director of the National Institute of Pharmaceutical Education and Research (NIPER), Punjab. Professor Bhutani assumed charge on December 31, 2009. He succeeds professor P Rama Rao who held the office from July 2004 to December 2009.